Attached files

file filename
EX-99.1 - 2017 01 10 NSH 8-K EXHIBIT 99.1 [REG FD UBS] - NuStar GP Holdings, LLCa20170110nshexhibit991re.htm


 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  
 
 
 
 
 FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 10, 2017
NuStar GP Holdings, LLC
(Exact name of registrant as specified in its charter)
Delaware
001-32940
85-0470977
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
 
 
 
 
19003 IH-10 West
San Antonio, Texas 78257
 
 
(Address of principal executive offices)
 
 
 
 
 
(210) 918-2000
 
 
(Registrant’s telephone number, including area code)
 
 
 
 
 
Not applicable
 
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 






Item 7.01    Regulation FD Disclosure.

Senior management of NuStar GP Holdings, LLC (the “Company”) is meeting with members of the investment community at the UBS MLP One-on-One Conference in Park City, Utah on January 10, 2017. The slides attached to this report were prepared in connection with, and are being used during, the conference. The slides are included in Exhibit 99.1 to this report and are incorporated herein by reference. The slides will be available on the “Investors” section of the Company’s website at www.nustargpholdings.com at 9:30 a.m. (Central Time) on January 10, 2017.


Item 9.01    Financial Statements and Exhibits.

(d)     Exhibits.

Exhibit Number
 
Exhibit
 
 
 
Exhibit 99.1
 
Slides to be used on January 10, 2017.


2



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
NUSTAR GP HOLDINGS, LLC
 
 
 
Date: January 10, 2017
By:
/s/ Amy L. Perry
 
Name:
Amy L. Perry
 
Title:
Senior Vice President, General Counsel - Corporate & Commercial Law and Corporate Secretary


3



EXHIBIT INDEX
Exhibit Number
 
Exhibit
 
 
 
Exhibit 99.1
 
Slides to be used on January 10, 2017.


4